Filing Details
- Accession Number:
- 0001209191-12-000914
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-01-04 13:50:35
- Reporting Period:
- 2012-01-03
- Filing Date:
- 2012-01-04
- Accepted Time:
- 2012-01-04 13:50:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339455 | Somaxon Pharmaceuticals Inc. | SOMX | Pharmaceutical Preparations (2834) | 200161599 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1362822 | Matthew Onaitis | Somaxon Pharmaceuticals, Inc. 10935 Vista Sorrento Pkwy., Ste. 250 San Diego CA 92130 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-01-03 | 9,000 | $0.48 | 155,037 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person with the proceeds remitted to the Company to cover the taxes withheld upon the vesting of 10,000 restricted stock units on December 31, 2011 and 10,000 restricted stock units on January 1, 2012.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4501 to $0.498, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
